Free University of Berlin   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Berlin Germany (1948)

Organization Overview

First Clinical Trial
2000
NCT00157378
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Charité-Universitätsmedizin Berlin, Dept Dermatology, Germany | Department of Psychiatry University FU Berlin | Dr. med. univ. L. J. Lehner | Klinikum Westend, Berlin

Active Ingredients

Drugs in Phase 4 Trials (4)

galantamine (reminyl) (1 trial)

haloperidol (haldol) (1 trial)

memantine (namenda) (1 trial)

risperidone (risperdal) (1 trial)

Drugs in Phase 3 Trials (1)

lh-8 (1 trial)

Drugs in Phase 2 Trials (2)

apremilast (otezla) (1 trial)

inactivated influenza vaccine (1 trial)

Drugs in Other Trials (1)

tacrolimus (prograf) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alopecia (Phase 3)

Alopecia Areata (Phase 3)

Alzheimer Disease (Phase 4)

Arthritis (Phase 2)

Arthritis, Psoriatic (Phase 2)

Influenza, Human (Phase 2)

Schizophrenia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 8